Eximore
Leadership

Our company was founded by leaders in ophthalmological practice and research, along with respected business advisors, and an experienced board. Together we are working to advance the capabilities and outcomes of ophthalmic treatments through innovative technologies and research. Meet the minds behind our solutions below.

Eximore Leadership Hero Image

The Team

Executive Leadership

EYAL SHEETRIT, MSc & MBA

Co-Founder & CEO

YANIV BARKANA, MD

Chief Medical Advisor

GUY TOMER, PhD

VP, Research & Development

TAL LAVI, PhD

Clinical & Operations Consultant

Advisors

GUY BEN SIMON, MD

Co-Founder, Eximore
Professor of Ophthalmology, Sheba Medical Center

XINGHUAI SUN, MD

President, Eye & ENT Hospital (Shanghai)

ZUGUO LIU, MD & PhD

Professor & Director of Eye & Stem Cell Institute, Xiamen University

Board Members

RICHEL LIU

Founder & CEO, Rimonci Capital

YAFIT STARK, PhD

Former Chief Clinical Officer, Teva Pharmaceuticals

ORI CHOSHEN

CEO, VLX Ventures

About Eximore

Eximore is a biopharmaceutical platform company focused on designing innovative solutions for the ophthalmological community. Our revolutionary integrated “Pack & Release” delivery system offers the potential to transform ophthalmic drug delivery, to increase compliance, to optimize consistency and improve patient outcomes, all while using an economical and scalable platform. Contact us to learn more.

Contact Us

© Copyright 2024 Eximore, Inc.

Sitemap | Privacy Policy